Byline Bancorp, Inc. filings document the disclosure record of a Delaware bank holding company and its Byline Bank operations. Form 8-K reports furnish quarterly financial results, related presentation materials, and material-event disclosures covering operating performance, capital management, and balance-sheet actions.
The company's regulatory filings also address stock repurchase authorizations, redemption of subordinated notes, changes in the independent registered public accounting firm, and annual proxy matters. Proxy disclosures cover board and governance items, executive compensation, equity awards, and shareholder voting matters relevant to the company's public-company structure.
Byline Bancorp, Inc. reported third‑quarter results for the period ended September 30, 2025. Net income was $37.2 million and diluted EPS was $0.82, up from $30.3 million and $0.69 a year ago. Net interest income rose to $99.9 million as total interest expense declined year over year. The provision for credit losses was $5.3 million, and non‑interest income totaled $15.9 million led by higher gains on loan sales.
Total assets reached $9.81 billion with net loans and leases at $7.34 billion. Deposits were $7.83 billion, and other borrowings decreased from year‑end. Stockholders’ equity increased to $1.24 billion as accumulated other comprehensive loss narrowed. The company reported $60.5 million in non‑interest expense, including salaries and benefits of $37.5 million.
During the nine months, the company raised $74.0 million net from subordinated debt, paid $13.7 million in common dividends, and repurchased shares. Common shares outstanding were 45,819,227 as of November 3, 2025.
Byline Bancorp, Inc. filed an amended Form S-4 to conduct an exchange offer for up to $75,000,000 aggregate principal amount of its 6.875% Fixed-to-Floating Rate Subordinated Notes due 2035. Holders may exchange their unregistered notes for registered notes on a like-for-like principal basis, subject to customary conditions, and the offer is not conditioned on any minimum tender.
The company will receive no cash proceeds and will bear the exchange costs. Old notes accepted in the offer will be retired and cancelled, so the exchange will not increase indebtedness. The new notes are subordinated obligations, mature on August 15, 2035, pay a fixed 6.875% until August 15, 2030, then float at Three‑Month Term SOFR + 322 bps, with optional redemption on interest dates beginning August 15, 2030 and upon specified regulatory or tax events.
The notes will not be listed, and there is no existing public market. For 180 days after consummation, broker‑dealers receiving new notes for market‑making may use this prospectus for resales. As of September 30, 2025, Byline reported total assets of $9.8 billion, deposits of $7.8 billion, and stockholders’ equity of $1.2 billion.
Byline Bancorp (BY) disclosed that a company officer sold 23,400 shares on 10/28/2025 across two open-market transactions: 3,400 shares at $26.9755 and 20,000 shares at $26.8715. After these sales, the officer directly holds 38,882 shares.
Byline Bancorp (BY) director filed a Form 4 showing an open‑market purchase (code P) of 65 shares on 10/28/2025 at $27.5575 per share.
After the transaction, beneficial ownership is 14,089 shares held indirectly via the William G. Kistner Trust dated June 22, 1973, and 1,036 shares held directly.
Byline Bancorp, Inc. furnished materials related to its third-quarter 2025 results. The company announced a press release for the quarter ended September 30, 2025 and made an accompanying slide presentation available.
Both documents were posted on October 23, 2025 and will support a publicly accessible conference call on October 24, 2025. The materials are furnished, not filed, under the securities laws and are included as Exhibits 99.1 (press release) and 99.2 (slides), with Exhibit 104 providing the cover page Inline XBRL data.
BlackRock, Inc. filed a Schedule 13G reporting beneficial ownership of 2,300,335 shares of Byline Bancorp, Inc. common stock, representing 5.02% of the class as of the event date 09/30/2025.
BlackRock reports sole voting power over 2,231,199 shares and sole dispositive power over 2,300,335 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Dimensional Fund Advisors LP reported on 09/30/2025 that it beneficially owns 2,322,339 shares of Byline Bancorp Inc. common stock, representing 5.1% of the class. Dimensional reports sole voting power over 2,283,888 shares and sole dispositive power over 2,322,339 shares.
The filing clarifies these shares are held on behalf of various funds and accounts advised or sub-advised by Dimensional, which disclaims beneficial ownership of the securities. The Schedule 13G indicates the position was reported under passive/investment-adviser disclosure standards and signed by Dimensional's Global Chief Compliance Officer on 10/09/2025.
Byline Bancorp, Inc. filed a current report to disclose that on October 1, 2025 it redeemed the entire $75,000,000 outstanding principal amount of its 6.000% Fixed-to-Floating Rate Subordinated Notes due 2030.
The notes were redeemed at 100% of their aggregate principal amount, plus accrued and unpaid interest up to, but excluding, the redemption date, in accordance with the subordinated debt indenture and first supplemental indenture. Holders receive this redemption price upon surrender of their notes to U.S. Bank Trust Company, National Association, acting as trustee and paying agent.
BYLINE BANCORP, INC. (BY) reporting person Dana Rose, identified as Chief Human Resources Officer and director, sold 1,999 shares of common stock at a price of $28.7601 per share on 09/12/2025. After the transaction she beneficially owned 10,192 shares, held directly. The Form 4 discloses a routine non-derivative disposition and is signed by an attorney-in-fact for the reporting person.
BYLINE BANCORP, INC. Form 144 notice reports a proposed sale of 1,999 common shares through Merrill Lynch on the NYSE, with an aggregate market value of $57,400 and 45,864,926 shares outstanding. The sale is scheduled for 09/12/2025. The shares to be sold match recently acquired stock awards: 444 shares granted 02/28/2022 and 1,555 shares granted 02/22/2025; both listed as compensation and acquired from the issuer. The filer reports no other sales in the past three months and affirms no undisclosed material adverse information.